WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments

Not Applicable

Completed

Conditions: Organizational Support for Evidence-based Public Health

Interventions: Other: Dissemination of public health knowledge

First Posted Date: 2017-07-07

Last Posted Date: 2023-02-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 331

Registration Number: NCT03211832

Locations: 🇺🇸
Prevention Research Center, Brown School, Washington University in St. Louis, Saint Louis, Missouri, United States

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Phase 1

Completed

Conditions: Graft-versus-host-disease
Graft Vs Host Disease

Interventions: Drug: Belimumab

First Posted Date: 2017-07-05

Last Posted Date: 2024-03-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT03207958

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Text Based Mobile Technology and Weight Loss

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Control Condition
Behavioral: CareMessage™

First Posted Date: 2017-06-29

Last Posted Date: 2019-02-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 35

Registration Number: NCT03203655

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy

Phase 1

Terminated

Conditions: Triple-negative Breast Carcinoma
Triple Negative Breast Cancer
Triple Negative Breast Neoplasms
TNBC - Triple-Negative Breast Cancer

Interventions: Drug: Durvalumab
Biological: Neoantigen DNA vaccine
Device: TDS-IM system (Inchor Medical Systems)
Procedure: Peripheral blood draw

First Posted Date: 2017-06-26

Last Posted Date: 2024-05-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT03199040

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Helping Poor Smokers Quit

Not Applicable

Completed

Conditions: Nicotine Dependence Tobacco Product
Smoking, Cigarette
Tobacco Use
Smoking, Tobacco
Smoking (Tobacco) Addiction
Tobacco; Use, Rehabilitation
Nicotine Use Disorder
Smoking, Pipe
Tobacco Use Cessation
Smoking Cessation

Interventions: Behavioral: Specialized Quitline
Behavioral: Basic Needs Navigator

First Posted Date: 2017-06-21

Last Posted Date: 2023-12-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1944

Registration Number: NCT03194958

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics

Phase 4

Withdrawn

Conditions: Postdural Puncture Headache
Cerebrospinal Fluid Leak
Spinal; Puncture, Complications, Headache

Interventions: Drug: Lidocaine 4%
Drug: Placebo

First Posted Date: 2017-06-08

Last Posted Date: 2019-02-12

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03181464

Locations: 🇺🇸
Washington University in St Louis School of Medicine, Saint Louis, Missouri, United States

Physical Therapy and Deep Brain Stimulation in Parkinson Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Physical Therapy

First Posted Date: 2017-06-08

Last Posted Date: 2023-03-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT03181282

Locations: 🇺🇸
Washington University in St. Louis School of Medicine - Program in Physical Therapy, Saint Louis, Missouri, United States

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

Not Applicable

Completed

Conditions: Soil Transmitted Helminths
Lymphatic Filariases
Scabies
Impetigo

Interventions: Drug: 2 drug dose - DA
Drug: 3 drug dose - IDA with second dose of ivermectin
Drug: 3 drug dose - IDA

First Posted Date: 2017-06-06

Last Posted Date: 2020-12-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4773

Registration Number: NCT03177993

Locations: 🇫🇯
Ministry of Health and Medical Services, Suva, Fiji

Scalp Block: Hemodynamic Stability and Patient Comfort In Craniotomy Patients

Phase 1

Withdrawn

Conditions: Tumor, Brain
Anesthesia, Local

Interventions: Drug: Lidocaine
Drug: Sodium chloride
Drug: Bupivacaine

First Posted Date: 2017-06-06

Last Posted Date: 2020-10-22

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03177252

Scale Down for Endometrial Cancer

Not Applicable

Completed

Conditions: Cancer of the Endometrium
Endometrial Cancer

Interventions: Behavioral: ScaleDown
Behavioral: Enhanced Usual Care Packets
Other: 12-Item Short Form Health Survey
Other: International Physical Activity Questionnaire short form
Other: Multidimensional Body Self Relations Questionnaire - Appearance Subscales
Other: Cancer-Related Body Image Scale
Other: Patient Health Questionnaire 9-Item Version
Behavioral: iOTA

First Posted Date: 2017-05-30

Last Posted Date: 2019-02-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 155

Registration Number: NCT03169023

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy